| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phathom Pharmaceuticals, Inc. (PHAT) has 10 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. PHAT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 379.6K | $4.69M | - | |
| CFO | 226.7K | $2.80M | - | |
| Other | 90.2K | $1.11M | - | |
| Dir | 67.5K | $834.3K | - | |
| Other | 47.8K | $591.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Breedlove Robert Charles | Principal Accounting Officer | Sell | 524 | $13.51 | $7,079.24 | -1.1% | +0.6% | - | |
| Sep 5, 2025 | Breedlove Robert Charles | Principal Accounting Officer | Sell | 461 | $12.09 | $5,573.49 | -1.0% | +19.1% | - | |
| Jul 16, 2025 | Breedlove Robert Charles | Principal Accounting Officer | Sell | 1,692 | $8.36 | $14,151.72 | -3.4% | +50.1% | - | |
| May 21, 2025 | Topper James N74 | Director | Buy | 3,780 | $3.86 | $14,609.32 | +6.8% | +166.2% | - | |
| May 14, 2025 | Topper James N74 | Director | Buy | 7,420 | $3.30 | $24,462.49 | +7.6% | +219.4% | - | |
| May 12, 2025 | Topper James N74 | Director | Buy | 48,203 | $3.17 | $152,916.63 | +69.9% | +226.3% | - | |
| May 7, 2025 | Parikh Asit86 | Director | Buy | 10,000 | $2.50 | $24,984.50 | +5.7% | +249.2% | - | |
| Apr 7, 2025 | Henderson Molly52 | CFO And Cbo | Sell | 3,678 | $4.55 | $16,739.68 | -3.9% | +77.8% | +137.2% | |
| Mar 13, 2025 | Parikh Asit86 | Director | Buy | 10,000 | $4.42 | $44,200.00 | +13.2% | +114.2% | +145.7% | |
| Jan 21, 2025 | Henderson Molly52 | CFO And Cbo | Sell | 6,583 | $6.59 | $43,370.78 | -6.6% | -42.6% | +100.4% |